When Robins, Kaplan, Miller & Ciresi L.L.P obtained a $26 million patent infringement verdict in April 2006 for its client, TriStrata, prejudgment and post-judgment interest added $14 million.
The U.S. District Court for the District of Delaware in Wilmington, Del. issued a final judgment March 31 granting prejudgment and post-judgment interest to TriStrata Technology, Inc., concluding its patent infringement lawsuit against Mary Kay Inc. The Court also granted TriStrata’s motion for a permanent injunction enjoining Mary Kay against making or selling the infringing products.
Last March, a jury found that Mary Kay infringed several patents owned by TriStrata related to alpha-hydroxyacid (AHA) skin care technology and awarded TriStrata more than $26 million in damages. With interest now determined, the total verdict amount is more than $40 million.
"The prejudgment interest is to be calculated based on the prime lending rate, compounded quarterly, since Feb. 1, 1995, and the post-judgment interest is at 4.77% compounded annually from the order date. This will bring the total verdict to well over $40 million," said TriStrata’s lead trial attorneys, Michael V. Ciresi and Jan M. Conlin of Robins, Kaplan, Miller & Ciresi L.L.P.
Read the full press release here.